Inhibitors of c-fms kinase
The invention is directed to compounds of Formula I:
Janssen Pharmaceutica NV
C C A A A C A A A A A A A A A C A A A A A C A A A C A A C A A A A A A A C
C07D C07D A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D A61P A61P A61P C07D A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Renee Louise Sanath K. Carl R. Kenneth J. Mark Jinsheng Shelley K.
Desjarlais Meegalla Illig Wilson Wall Chen Ballentine